OTC · Medical - Specialties

Avitar, Inc. (AVTI) Stock

$0.00 OTC: AVTI Healthcare

Avitar, Inc., through its subsidiaries, designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine, such as crack; marijuana; and methamphetamines, including meth and ecstasy.

Valuation

MetricValue
Price$0.00
Market Cap$1382
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.01
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE20.00%
ROA-101.06%
ROCE-100.86%
Gross Margin23.36%
Operating Margin-160.75%
Net Margin-99.36%
Debt/Equity-0.50
Current Ratio0.09

Annual Financials (USD)

Metric20032004200520062007
Revenue$5.0M$4.0M$5.0M$5.0M$3.0M
Operating Profit$3.0M$3.0M$4.0M$3.0M$3.0M
Net Profit$-6.0M$-3.0M$-2.0M$-4.0M$-2.0M
EPS$-5.11$-1.39$-0.83$-0.76$-0.11
Op Margin69.7%65.0%84.9%64.3%88.0%

Balance Sheet (USD)

Metric20032004200520062007
Total Assets$4.0M$2.0M$2.0M$2.0M$2.0M
Total Liabilities$5.0M$3.0M$7.0M$11.0M$12.0M
Cash$1.0M$1.0M$0$0$0
Borrowings$2.0M$0$2.0M$4.0M$5.0M

Cash Flow (USD)

Metric20032004200520062007
Operating Cash Flow$-2.0M$-4.0M$-4.0M$-3.0M$-2.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$1.0M$-1.0M$0$0$0
Free Cash Flow$-2.0M$-4.0M$-4.0M$-3.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-3.10
FCF Yield-129502.46%
Quick Ratio0.09
Interest Coverage5.73
Return 1Y0.00%
Return 3Y0.00%
Return 5Y

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BMGPBiomagnetics Diagnostics Corp. $0.00 0.00 $1265 0.00%
CNTTQCannTrust Holdings Inc. $0.00 0.00 $1412 0.00%
FDBHFounders Bay Holdings $0.00 0.00 $25036 0.00%
IXSBFInNexus Biotechnology, Inc. $0.00 0.00 $12627 0.00%
ORHBORHub, Inc. $0.00 -0.01 $27500 0.00%

About Avitar, Inc.

Avitar, Inc., through its subsidiaries, designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine, such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products, including medical-grade hydrophilic polyurethane foam disposables, such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. In addition, it develops specialty wound dressings for the cardiac catheter lab market and the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures. The company markets its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales force and strategic partners, as well as through a network of distributors. Avitar, Inc. was founded in 1986 and is based in Canton, Massachusetts.

Avitar, Inc. (AVTI) stock trades at $0.00 with a market capitalization of $1382. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.01. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Avitar, Inc. generates a return on equity (ROE) of 20.00%, above the typical market average, return on capital employed of -100.86%, an operating margin of -160.75%, a net profit margin of -99.36%.

Official website: www.a-vantti.cz

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides